Immediate Impact
63 standout
Citing Papers
New clinical trial design in precision medicine: discovery, development and direction
2024 Standout
Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies
2024 Standout
Works of Joseph Kupferman being referenced
Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Joseph Kupferman | 101 | 48 | 134 | 104 | 11 | 366 | |
| Antoine Abcar | 94 | 15 | 167 | 9 | 12 | 357 | |
| Sandra Rutz | 69 | 34 | 145 | 8 | 13 | 312 | |
| Rumiana S. Chuknyiska | 31 | 14 | 84 | 19 | 11 | 368 | |
| Jan B. Koenderink | 49 | 20 | 40 | 24 | 13 | 389 | |
| Anna Bobrowska | 49 | 31 | 44 | 18 | 11 | 395 | |
| Jing Xu | 10 | 41 | 168 | 56 | 14 | 399 | |
| Jade Berg | 24 | 6 | 72 | 22 | 11 | 334 | |
| Teresa Chen | 15 | 19 | 56 | 14 | 10 | 379 | |
| Mutsuko Nagata | 29 | 10 | 68 | 11 | 12 | 346 | |
| Noemí Ceprián | 67 | 13 | 82 | 9 | 21 | 365 |
All Works
Loading papers...